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Highly distinguished prorector, dean, 
Highly distinguished colleagues professors, 
Dear colleagues, 
Dear family and friends,
Ladies and gentlemen,
 When Roentgen discovered the X Rays 115 years ago, a giant step was 
made in mankind. For the first time we were able to look at diseases. 
But spectacular advances in imaging were only made during the last 40 
yrs. Hounsfield, the discoverer of Computed Tomography (CT), Mansfield 
and Lauterbur, discoverers of Magnetic Resonance Imaging (MRI), were 
all great men that has preceded us.
 In 2001 healthcare providers in the US were asked what they thought 
were the 5 most important developments in medical technology in the last 
30 yrs. Their answer was nr 1: CT and MRI, nr 2 & 3: balloon angioplasty and 
intervention and nr 5: mammography. 
 Why mammography? Radiologists not only deal with patients but 
also with healthy people. Mammography is used in population based 
breast cancer screening and reduces cancer death. We have learnt from 
Prof Boetes in her inaugural lecture  that also MRI has potential for future 
breast screening. Bowel cancer screening is on its way. We can screen 
with fecal occult blood test, with endoscopy, and even with imaging. We 
fly through the bowel and search for polyps like the endoscopist does 
but now with CT, CT colonography. Prof Jaap Stoker from AMC does a 
lot of great work in CT colonography to determine its cost efficency for 
bowel cancer screening.  
CT colonography, courtesy J. Stoker, AMC.
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narrow our target and focus only on the two terrorists. But to do so we 
need to use each and every tool that we have obtain our goal. In such as 
situation we will kill the bad but save the good. 
This is what personalized medicine is all about. It is “ the right treatment 
for the right person at the right time”. Personalized medicine increases 
the therapeutic index, decreases the number needed to treat and reduces 
the cost. In the pursuit of personalized medicine we need to develop new 
imaging tools that can help us understand the pathways of new cancer 
treatment and help for better selection of the patients. 
 We can now image detailed morphology but we will learn that mor-
phology alone is not sufficient. Changes in morphology do not occur at 
the same speed as changes in biology. So we need to image in a different 
way, image tumor biology, tumor metabolism, its genetic and protein 
information. 
Imaging diagnosis will from now on not be about straight or clearly 
defined diagnosis, but will be about integrated diagnosis. Integrating 
imaging data with tumor molecular profile to generate the most probable 
diagnosis. 
Modern cancer imaging
We are entering a new area of imaging, the area of Molecular Imaging 
(MI). MI is expecting to really change the way we diagnose, treat, and do 
the follow up of cancer patients. Among the most promising MI methods 
today is PET, Positron Emission Tomography. Here is an FDG PET-CT of 
patient with lymphoma. That is PET combined with CT. FDG is a glucose 
tracer most used in oncology PET imaging, fluorodeoxyglucose (18F). The 
principle is that tumor cells have a higher glucose metabolism than normal 
cells. This is why they take up FDG.  It is amazing how imaging can tell the 
medical oncologist how the tumor is responding to his treatment. 
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FDG PET-CT of a patient with lymphoma, courtesy E. Rummeny, Univ Hospital München.
But not all cancer types are visible on FDG PET because not all takes up 
FDG in the same way. Fortunately there’s a menu of PET tracers today 
and these are just a few. 18 Fluoride PET tracers, promising in oncology.
 Here the bone scan of a patient with metastases from his prostate 
cancer. The dark spots are the metastases. On the right is his 18 Fluoride PET 
scan. Many more lesions can be seen. It is frightening how many lesions 
we see today that we have missed yesterday as we can image more 
precisely. Here the FDG PET of two patients with metastases from breast 
cancer. Both breast tumors had estrogen hormone receptors on their 
tumor cells. So when they develop metastases they can be treated with 
a drug that suppresses the estrogen receptor. Following this treatment, 
patient 1 showed excellent response on FDG PET. Patient 2 no response 
at all. How can it be? Well we know: if the breast cancer is estrogen 
receptor positive (ER positive), the metastasis must be ER positive too. 
But imaging clearly tells us that this is not true at all. Here is an estrogen 
receptor PET scan using another PET tracer  18 Fluoride Estradiol Tracer 
(FES PET). This tracer binds to the estrogen receptors of a tumor cell. 
Patient 1 her metastasis had estrogen receptors and as you can see from 
her FES PET, the receptor suppressing drug binds to the receptors and 
kill the tumor cells. That is why patient 1 shows response. Patient 2 her 
metastases did not have estrogen receptors. So an ER suppressing drug 
would not bind and thus not work in this patient. That is why there is no 
response in patient 2. 
This is a very intelligent therapy that requires intelligent imaging. 
Imaging that helps clinicians to understand the pathways of their treat-
ment: diagnostics being used to guide therapeutics.  
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It looks like PET but it is Diffusion MRI. Diffusion MRI tells us which is 
tumor and which not because it can capture the differences in move-
ments of water molecules in tumor and healthy tissue. Unlike PET, it 
does not expose the patient to radiation. And you can even display it in 
every way that makes you more comfortable to look at the lesion. 
We are developing technology continuously. There will be PET and MRI in 
1 machine: PET- MRI. These are fusion images but PET- MRI for oncology 
will soon be reality.  PET and MRI, the cornerstones of cancer imaging 
now and in future. They are complementary rather than competitive and 
combined they give the best of both worlds, molecular and morphology 
imaging. 
 Interventional radiologists in oncology use minimal invasive ways to 
kill tumor cells. Embolizing of liver tumors is one example. Cutting of 
tumor blood supply by clogging the vessels with beads.  At Memorial 
Sloan Kettering Cancer Center, where  my husband and me had the 
privilege to work during the past year, interventional radiologists use 3 
dimensional images that they generate during the interventional procedure. 
It helps them to learn the consequences of his actions. When they do it 
wright and position the catheter here, the tumor vessels, will be clogged. 
But when they position the catheter there, then these vessels will be 
clogged which are normal liver feeding vessels, so normal liver will be 
damaged. 
We also do biopsies. Take tumor samples for tissue analysis. That can 
be very difficult in small organs like prostate. But we have imaging to 
guide us, US but also MRI. Here you can see how MRI guides our needle 
to exactly hit our target  the tumor in the prostate. 
 
Computing and augmented imaging
More sophisticated imaging is on the horizon to guide us in intervention. 
Imaging by computing. Virtual reality that shows us where exactly we 
are during the procedure. 
There is robotic surgery. It is an amazing piece of technology where 
robotic hands can extend the surgeons hands and scales down the 
motions to microanatomy level and magnifies the field in 3 Dimensions. 
It is often performed in prostate cancer surgery. Imaging by computing 
will allow the surgeon to prepare his complex surgery beforehand and 
limit the moments where he might be unpleasantly surpised by anatomy. 
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Computing images will help him not only before the surgery but also 
during the procedure. Because there will be augmented imaging. 
Imaging that overlays the virtual anatomy of the patient and the real 
anatomy. It can tell the surgeon where exactly he is during the surgery. 
 Computing images and augmented images. Those will be the images 
of tomorrow that we’ re now only dreaming about.  
Collaboration 
The matrix for success in cancer medicine is multi-disciplinary team 
approach. Multidisciplinary teams (MDT) consist of surgeons, radiothe-
rapists, medical oncologists subspecialized in certain cancer types. They 
manage the patient together as a team of experts. Expert treatment 
requires expert diagnosis. It is therefore inevitable that radiology and 
the radiologist’s role change. From technology centered to patient 
centered, from general to subspecialized radiologists. This change has 
already taken place in cancer imaging. It is in the field of oncology that 
our imaging  can so much influence treatment decision making. I want 
to illustrate it with the following.
MR image of a patient with rectal cancer. Here is the tumor. It extends to 
the surgeon’s resection margin, over here. What happens when we don’t 
use imaging? The surgeon would cut right through the tumor and leave 
tumor remnants  behind. The patient is now at risk for a recurrence and 
distant spread. But because there is imaging the expert team decides 
not to resect it right away but first irradiate the tumor. Then the radio-
logist points at this node, he thinks it might be involved. This node is in 
the surgical field so that’s not a problem, it will be removed anyway. But 
this node is outside the surgeons field. If there was no imaging we would 
have overlooked the suspicious node. Now the team can tailor their 
treatment to this patient’s need. The radiation oncologist decides to 
give a higher dose to the node to sterilize it and the medical oncologist 
adds chemotherapy to minimize the risk for distant tumor spread. This 
is cancer imaging that truly contributes to treatment decision making. 
 The use of modern imaging, no matter how fancy, would not make 
any sense if it does not impact patient’s outcome. The use of imaging 
in medicine is worldwide expanding and so are the costs. So when new 
imaging technologies have been validated the next wright step is to 
study this technology within the context of a clinical trial with patient’s 
outcome as the primary endpoint. Only this will determine the true 
value of the diagnostic tool. 
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 We performed such a study in our region. We scanned all rectal can-
cer patients with MRI, we let MRI tells us which are the good, the bad 
and the ugly tumors and gave different treatments base don the MR 
findings. The outcome improved: the local recurrence rate decreased 
from 40% in the old days, dropped down to 11% with better surgery 
and further down to well below 5 % with better imaging. If you look at 
this map, it is striking that in our catchment area there were less rectal 
cancer deaths when we started to use MRI in all patients. Obviously 
this is due to many factors, not only because of better imaging but also 
because of better surgery, better radiotherapy, better chemotherapy as 
well. So it’s clear that we have to get radiologists in the middle of the 
MDT. This is the only way we can keep up with the high requirements in 
cancer imaging. 
 Close Collaboration with clinicians, it may sound so obvious, yet it’s 
not. I remember very well when in 2003, not even a long time ago, it was 
dicussed within the european radiology society whether or not we would 
benefit from clinical education in our meetings. Radiology was then not 
ready. But it’s changing now. This year multidisciplinary teaching courses 
in cancer were organized for the very first time at the annual meeting 
of the European Society of Radiology (European Congress of Radiology, 
ECR 2010) and because of the growing need for clinical education, it will 
become one of the main educational streams in future ECR’s.
 We are becoming more aware that we cannot practice radiology in 
isolation. When we subspecialize we will lose general knowledge. But we 
will gain new others and improve our quality. We can be of even greater 
value than ever before, because we combine our skills in technology with 
know how in therapy. 
But to become good, we need to invest. Because to offer a wright answer 
to a question we first need to understand the question. So I encourage 
colleagues radiologists to seek education not only inside but also out-
side our specialty. These are the moments where we get to know the 
dynamics in the specialties around us, where we get to understand their 
questions.
 There are many occasions to do so. The Dutch Colorectal Cancer 
Group (DCCG) represents the essential collaboration between the different 
disciplines in research and clinical practice and aims at monitoring 
and improving the quality of diagnosis and treatment of patients with 
colorectal cancer. The group organizes dutch and international meetings 
where we learn from each other, from clinicians from the different disci-
plines. I am happy to see an increasing number of colleagues attending 
Imaging in Oncology
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these multidisciplinary meetings among whom many radiologists. But 
other occasions will soon follow. Collaboration is already starting to 
take place at the level of societies. The European Schools of Radiology 
and Radiation Oncology will organize joint postgraduate courses for 
radiologists and radiotherapists. The European Society of Abdominal 
Radiology (ESGAR) has teamed up with the United European Federation 
of Gastroenterology and has representatives in educational and future 
trend committees. The ESGAR has also started collaboration with the 
European  Society Digestive Oncology. Radiology is ready to get in the 
middle of the MDT.
Ownership 
 This brings me to the following. Exchange of knowledge means share 
of knowledge. Until now imaging facilities have redominantly remained 
in the domains of the radiologist. Imaging has so far mainly been used 
by radiologists and nuclear physicians. But this will change, especially 
in oncology. A change in the organization of hospital departments has in 
fact already happened years ago. Numerous facilities in clinics are collec-
tively used by different specialties: operating rooms are not owned by 
surgeons, Intensive Care Units have become independent of cardiology 
or neurology. So there is no specific reason why imaging facilities should 
not be located elsewhere in hospital and why imaging should not be 
used by clinicians. 
Radiation oncologists. They use imaging. PET helps them for precise 
definition of their tumor target and this is important for modulated 
radiotherapy. 
Surgical oncologists. They use imaging. This is the setup of an operating 
theatre for cancer surgery in Maastricht. Time has passed that surgeons 
only read reports and did not look at images. A picture tells us more 
than thousand words and it is so true also for surgeons. But to use the 
pictures they need to understand these. 
 As much as we learn from clinicians, we need to be willing to teach 
back. We cannot monopolize imaging because we cannot monopolize 
knowledge. We can invent and investigate, but thereafter we need to 
share. This is what happens in research. But this should also happen in 
treatment, in imaging.  
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Because think about this. “Do we really own radiology?”. What in fact is 
radiology? Yes, you can own a CT machine or an MR equipment but can 
you own knowledge ? If you don’t like the idea that clinicians become 
knowledgeable don’t become protective. Don’t let fear dictate how you 
act, because:  
Nothing in life is to be feared….it is only to be understood. 
            (Marie Curie)
So don’t waste time and energy in turf battles. But invest and excelI in 
knowledge. Because knowledge is power and knowledge gains respect. 
It is without doubt that imaging technology and diagnosis making pro-
cesses remain the mainstay of radiology. We invent, investigate, optimize 
and monitor new imaging technologies. We diagnose. These are skills 
that are truly ours, for which our colleagues really need us and above all 
respect us.
Reorganize  
Radiologists especially those working in the field of oncology process 
an increasing number of scans, learn about new molecular technology, 
interact with clinicians, learn about therapy and teach back on imaging. 
It is obvious that no single person can master this all. With subspeciali-
zation quality is high but organization even more complex. 
 So is it time now to change? Change the way we organize our work, 
our department, and our specialty?  Often when the question arises 
whether a change is needed, it ís time to change. 
 How to do this? Obviously there are many ways here are just a few. 
Training more radiologists is one priority but only solves the problem 
in the long run and is certainly not without increasing cost for society. 
Outsourcing of images to outside centers that report images from remote 
(teleradiology) could work but not in cancer imaging, where the focus is 
on multidiscplinary interaction. 
The use of computer programmes to assist us: Computer aided diagnosis. 
We, radiologists in oncology, spend endless of hours deciding based on 1 
single size diameter whether the tumor shows response, yet we know 
logically that our size measurements do not always indicate tumor res-
ponse. Not to speak about the high variability in reading results among 
different readers. You must admit that if you, colleague oncologists, look 
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at these images would you rather base your decision - whether or not 
you continue chemotherapy-  on this single size measurement, where 
there is no response or on this volume measurement that shows clear 
response?
But volume measurements are time consuming. So we need computers 
to assist us and free our time. Not at all pretending that it will substitute 
radiologists. We will always remain responsible for the final interpretation 
of an image. 
 Reallocating tasks to physician assistants or radiology technologists: 
radiology assistants. Radiology assistants work side by side and under 
supervision of a radiologist in the diagnosis making procedures. The 
study of professor van Engelshoven and Dr. Karin Flobbe in Maastricht 
has shown that this concept could work to free up the time of the breast 
radiologist. Their results showed that in breast cancer imaging radiology 
assistants can accurately select mammographies that have no abnor-
mality, leaving only the ones that need further evaluation to the breast 
radiologists.  No need to say that it should be implemented only under 
close monitoring and with regular training. 
 Reallocating tasks to physicists - biomedical engineers – informati-
cian technologists. There will be increasing quantifiable data from MI. 
Increasing computing and augmented imaging. It is high scientific tech-
nology know how that is not our expertise. These technology experts 
can alleviate our tasks by working side by side with us in clinical practice. 
In the Netherlands a study that combines the bachelors degree in tech-
nology science with a masters degree in medicine will result in the first 
technical-medical doctors to enter radiology in the coming years. But 
untill this will become reality and untill the shortage of radiologists will 
be filled, the demand will be high to have others to alleviate our tasks. 
 Reorganizing the imaging specialties, radiology and nuclear medicine. 
While in the US, nuclear medicine and radiology are located within the 
same department, in Europe they are separate and totally autonomous. 
The two specialties have similarities and differences. They both offer 
diagnosis and treatment and they both use radiation. The difference is 
that radiology focuses more on anatomy imaging while nuclear medicine 
on metabolism and biology imaging. Our imaging specialties are thus 
complementary and not competitive. 
With the increasing use of PET-CT in oncology and soon also PET-MRI the 
demarcation between the 2 specialties will become less evident. Board 
certified nuclear physicians and radiologists already seek education in 
each other’s field and double registrations are increasingly taking place. 
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Obviously double registration is an undesirable situation and turfbattles 
in diagnostic equipment even more. 
It is therefore time to revisit our specialties and recognize the synergy 
when the two merge into one. The sound base upon which this can be 
realized is in specialty training. Disease oriented training programmes in 
radiology and nuclear medicine incorporate periods of exchange in trai-
ning between the two specialties. Future will learn that disease oriented 
training in clinical, anatomical and molecular imaging will fully integrate 
and will result in the new generation imaging diagnosticians.  
Today’s radiologist will be tomorrow’s imaging specialist.
Imaging in Oncology, a new beginning has truly begun…… 
Imaging in Oncology
a new beginning has just begun…
18
Thank You…
When 2 years ago I was appointed the position of professor in Oncology 
Imaging at the medical faculty of Maastricht University, I was aware that 
I could not have achieved this position without the support and efforts 
of many, many people. And that I can only fulfill this challenging task 
with their continuous support.
Aware that I cannot be complete I would like to thank all those that have 
been with me. I wish I could name them one by one, but that is impossible. 
My gratitude goes to all of you.
First of all I thank God, who gave me the gift, the endurance and the 
wisdom.
I thank the patients, who even during the most difficult time of their lives, 
were able to give to others. You are the reason for which I will continue 
my work. 
I would like to thank the College van Bestuur of the University of 
Maastricht, the rector, the prorector, the dean of the Faculty of Health, 
Medicine and life science, Prof Martin Paul; I thank the Board of Directors 
of the University Hospital Maastricht for their trust in me. 
Prof van Engelshoven, emeritus professor and former chair of the radiology 
department at the University Hospital Maastricht. Dear Jos, you were the 
one who taught me the tricks of the trade, in radiology and in research. I 
pay tribute and respect for your vision as a leader. You accompanied me 
along the journey and gave me freedom to grow. It is because of you that 
I am in this position. I deeply thank you for your trust in me.  
Prof van Waes, emeritus professor and former chair of the radiology 
department at the University Hospital Utrecht. Dear Paul, you opened 
the door of radiology for me. You showed me the way into this specialty. 
Thanks for your unconditional trust in me. Thanks for being a mentor 
and a friend. 
I am honored with the presence today of highly distinguished guests, 
from different universities in the Netherlands and abroad. Thank you so 
much for attending my inauguration. 
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Colleague professors in surgery, in digestive oncology, in radiation onco-
logy from the Unversity Hospital Leuven. It is very rewarding to work 
with you both in education as well as in research. I hope to consolidate 
and expand our collaboration. 
Thanks especially to you here present, my colleagues and former trainers 
in radiation oncology. You introduced me into the world of Oncology and 
I thank you for that. 
My colleague board members of the ESGAR, of the DCCG, present here 
professor vd Velde, dear Cock, of the Dutch Society of Radiology, present 
here the president, professor Laméris, dear Han, thank you for the oppor-
tunities given to me to realize my mission for radiology. Thank you for 
our pleasant collaboration in work and for our friendship outside.
I thank my colleagues in the audience from far and abroad. It means a 
lot to me that you have traveled the long way to be here with me today. 
My sparing partners, clinical colleagues in so many multidisciplinary 
teams in our hospital and in the oncology center. The research partners 
and the directors of the oncology research school. There are too many to 
mention one by one.  My sincere gratitude for our excellent collabora-
tion, for your trust in me to build oncology imaging in Maastricht. 
A “thank you” goes to the department of radiology in Maastricht, each 
and every person who have contributed to my work, the secretarial 
office, my personal secretaries, technologists, physicists, all residents. 
Professor Wildberger, present chair of our department, Joachim, I wish 
you all the luck in building the department and I surely hope we can 
build together. 
Prof Boetes, Carla. Years ago we expressed our wish to work together. 
Our wishes came true. I am so glad that you are now here with me in 
Maastricht. 
My sincere gratitude to the attending staff of radiology, my colleagues: 
without your support I could not stand here today. 
A special word to Dr de Haan, dear Michiel, thank you for being my col-
league and friend.  To Dr Cappendijk, dear Vincent and to Dr Bakers, dear 
Frans, I cannot express in words my gratitude for your unconditional 
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support. I hope we will continue working together as a team for a long, 
long period .
Many many thanks to my research team, students and PhDs : Quido, Roy, 
Sanne, Elleke, Max, Doenja and Monique. It is a real joy working with you. 
You are the ones who – when the challenge seems the hardest, the pro-
blems insoluble and everyone else would shake their heads – say: “Let’s 
Go”. Your ambitions are high and my wish is to make your professional 
dreams come true. 
My family and beloved friends, many of you have come from far to be 
here with me. I cannot express my feelings. You mean a lot to me.
My inlaws, my father,my late mother in law, my sisters. Thanks for being 
such a great family. 
Dear Renate, dear Roger. I am so privileged to have you as my sister and 
my brother. I am very proud of you and of your families. 
Dear mom, unfortunately, dad is no longer with us. I want to thank you both 
for every moment in life, for giving me a future, for being my councellor, for 
your believe in me. Your love is unconditional and goes beyond all titles 
and achievements.
Dear Geerard, dear Nathalie. 
Geerard, if it wasn’t you that was with me in my life, I could not have 
made it. Every word that I say is not enough to express my love. You are 
my power. 
 
Nathalie, what can I say? When I wrote down these words of thanks, you 
looked at me and said : “you don’t write thanks, mammie, you pay thanks 
from within your heart” . You rock baby. You know that we both are proud 
of you, and will always be there for you because you are our number one. 
I have spoken.  

